143 related articles for article (PubMed ID: 8322491)
1. Recombinant vaccinia immunization in the presence of passively administered antibody.
Johnson MP; Meitin CA; Bender BS; Small PA
Vaccine; 1993; 11(6):665-9. PubMed ID: 8322491
[TBL] [Abstract][Full Text] [Related]
2. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
Galletti R; Beauverger P; Wild TF
Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
[TBL] [Abstract][Full Text] [Related]
3. Enteric immunization of mice against influenza with recombinant vaccinia.
Meitin CA; Bender BS; Small PA
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11187-91. PubMed ID: 7972032
[TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins.
Jakeman KJ; Smith H; Sweet C
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1523-31. PubMed ID: 2732721
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.
Bender BS; Rowe CA; Taylor SF; Wyatt LS; Moss B; Small PA
J Virol; 1996 Sep; 70(9):6418-24. PubMed ID: 8709274
[TBL] [Abstract][Full Text] [Related]
7. Characterization of antibody and cytotoxic T lymphocyte responses to human influenza virus H3 haemagglutinin expressed from the haemagglutinin locus of vaccinia virus.
Itamura S; Iinuma H; Shida H; Morikawa Y; Nerome K; Oya A
J Gen Virol; 1990 Dec; 71 ( Pt 12)():2859-65. PubMed ID: 2273387
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice.
Andrew ME
Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():339-41. PubMed ID: 2613281
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection.
Ben-Yehuda A; Ehleiter D; Hu AR; Weksler ME
J Infect Dis; 1993 Aug; 168(2):352-7. PubMed ID: 8335970
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
12. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML
J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931
[TBL] [Abstract][Full Text] [Related]
14. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.
Andrew ME; Coupar BE; Boyle DB; Ada GL
Scand J Immunol; 1987 Jan; 25(1):21-8. PubMed ID: 3492756
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vaccinia virus with influenza hemagglutinin protects old mice from influenza infection.
Ben-Yehuda A; Ehleiter D; Hu AR; Weksler ME
Trans Assoc Am Physicians; 1992; 105():177-81. PubMed ID: 1308994
[No Abstract] [Full Text] [Related]
16. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Coupar BE; Andrew ME; Both GW; Boyle DB
Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice.
Andrew ME; Coupar BE; Boyle DB
Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():331-7. PubMed ID: 2613280
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation.
Byars NE; Allison AC; Harmon MW; Kendal AP
Vaccine; 1990 Feb; 8(1):49-56. PubMed ID: 2316284
[TBL] [Abstract][Full Text] [Related]
20. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.
Bennink JR; Yewdell JW; Smith GL; Moller C; Moss B
Nature; 1984 Oct 11-17; 311(5986):578-9. PubMed ID: 6332992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
